Literature DB >> 12558142

Hemodynamic effects of early versus late glucocorticosteroid administration in experimental septic shock.

Arnaud Mansart1, Pierre Edouard Bollaert, Carole Seguin, Bruno Levy, Dan Longrois, Jean Pierre Mallié.   

Abstract

Recent findings in human septic shock suggest that glucocorticosteroids can limit and even reverse hemodynamic disturbances and dependence on catecholamines. In a rodent model of hypotensive and hypokinetic septic shock, we investigated the effects of early or late dexamethasone administration on hemodynamics, response to catecholamines, and cardiac beta-adrenergic signalling. As compared with sham-operated rats, the untreated septic rats displayed significant arterial hypotension and reduced aortic blood flow. However, in vivo pressor response to epinephrine and phenylephrine was not different among sham and septic animals. Conversely, the chronotropic response to isoproterenol was significantly attenuated in septic animals. Steroid-treated septic animals displayed complete reversal of hypotension, improvement in aortic blood flow, and reduced plasma lactate and nitrite/nitrate concentrations as compared with untreated septic animals. The number of myocardial beta-adrenergic receptors and in vivo isoproterenol-stimulated myocardial cAMP content were similar in sham and septic animals. Glucocorticosteroids, although not changing these patterns, significantly decreased the receptors affinity when administered late, but not early. In this model of septic shock, hemodynamic abnormalities may not be related to adrenergic receptor desensitization. That steroids can improve them suggests that they could act mainly distal to adrenergic receptors, for instance, on myocardial and vascular smooth fiber contraction properties through mechanisms probably including inducible nitric oxide synthase inhibition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12558142     DOI: 10.1097/00024382-200301000-00008

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  4 in total

1.  Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock.

Authors:  Sébastien Gibot; Cecilia Buonsanti; Frédéric Massin; Michele Romano; Marie-Nathalie Kolopp-Sarda; Fabio Benigni; Gilbert C Faure; Marie-Christine Béné; Paola Panina-Bordignon; Nadia Passini; Bruno Lévy
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock.

Authors:  Caitlin W Hicks; Daniel A Sweeney; Robert L Danner; Peter Q Eichacker; Anthony F Suffredini; Jing Feng; Junfeng Sun; Ellen N Behrend; Steven B Solomon; Charles Natanson
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

3.  Comparative effects of recombinant human activated protein C and dexamethasone in experimental septic shock.

Authors:  Youcef Bouazza; Nacira Sennoun; Charlène Strub; Véronique Regnault; Sebastien Gibot; Ferhat Meziani; Patrick Lacolley; Bruno Levy
Journal:  Intensive Care Med       Date:  2011-08-18       Impact factor: 17.440

4.  Risk of death does not alter the efficacy of hydrocortisone therapy in a mouse E. coli pneumonia model: risk and corticosteroids in sepsis.

Authors:  Yan Li; Xizhong Cui; Xuemei Li; Steven B Solomon; Robert L Danner; Steven M Banks; Yvonne Fitz; Djillali Annane; Charles Natanson; Peter Q Eichacker
Journal:  Intensive Care Med       Date:  2007-11-09       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.